Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-27
2006-06-27
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S510000, C549S511000, C548S311400, C514S397000
Reexamination Certificate
active
07067552
ABSTRACT:
Taxanes containing electron-affinic radiosensitizing functional groups, their pharmaceutical preparations, and methods of making and using this new class of highly potent radiosensitizers of tumor cells.
REFERENCES:
patent: 5250683 (1993-10-01), Holton et al.
patent: 5283253 (1994-02-01), Holton et al.
patent: 5648506 (1997-07-01), Desai et al.
Tishler, et al., “Taxol: A Novel Radiation Sensitizer,” Int. J. Radiat. Oncol. Biol. Phys., 1992, vol. 22, pp. 613-617.
Tishler, “Taxol Sensitizes Human Astrocytoma Cells to Radiation,” Cancer Res., 1992, vol. 52, pp. 3495-3497.
Steren, et al., “Taxol Sensitizes Human Ovarian Cancer Cells to Radiation,” Gynecol. Oncol., 1993, vol. 48, pp 252-258.
Steren, et al., “Taxol as a Radiation Sensitizer: A Flow Cytometric Study,” Gynecol. Oncol., 1993, vol. 50, pp. 89-93.
Hei, et al., “Taxol, Radiation, and Oncogenic Transformation,” Gynecol. Oncol., 1993, vol. 53, pp. 1368-1372.
Liebmann, et al., “Changes in Radiation Survival Curve Parameters in Human Tumor and Rodent Cells Exposed to Paclitaxel (Taxol®),” Int. J. Radiat. Oncol. Boil. Phys., 1994, vol. 29, No. 3, pp. 559-564.
Liebmann, et al., “In Vitro Studies of Taxol as a Radiation Sensitizer in Human Tumor Cells,” I. Natl. Cancer, 1994, vol. 86, No. 6, pp. 441-446.
Milas, et al., “Enhancement of Tumor Radioresponse of a Murine Mammaray Carcinoma by Paclitaxel,” Cancer Research, 1994, vol. 54, pp. 3506-3510.
Bocian, et al., “Sister chromatid exchanges induced by two radiosensitizing platinum compounds (cis-dichloro-bis isopropylamine transdihydroxy platinum IV (CHIP) and cis platinum metronoidaxole2Cl2(FLAP)) in CHO cells in vitro,” Br. J. Cancer, 1983, vol. 48, pp. 803-807.
Teicher, et al., “Radiosensitization of EMT6 Cells by Four Platinum Complexes,” Int. J. Radiat. Oncol. Biol. Phys., 1985, vol. 11, pp. 937-941.
Skov, et al., “Platinum Complexes with One Radiosensitizing Ligand [PtCl2NH3) (Sensitizer)]: Radiosensitization and Toxicity Studies in Vitro,” Radiat. Res., 1987, vol. 112, pp. 273-282.
Skov, et al., “Toxicity of [PtCl2(NH3)L] in hypoxia; L=misonidazole or metronidazole,” Anticancer Drug Dis., 1990, vol. 5, pp. 121-128.
Skov, et al., “Radiosensitization by metal complexes of 4(5)-nitroimidazole,” Int. J. Radiat. Biol., 1990, vol. 57, pp. 947-958.
Herman, et al., “Effect of Hypoxia and Acidosis on the Cytotoxicity of Four Platinum Complexes at Normal and Hyperthermic Temperatures,” Cancer Res., 1988, vol. 48, pp. 2342-2347.
Carboni, et al., “Synthesis of a Photoaffinity Analog of Taxol as an Approach to Identify the Taxol Binding Site on Microtubules,” J. Med. Chem., 1993, vol. 36, pp. 513-515.
Chen, et al., “Structure-Activity Relationships of Taxol® Synthesis and Biological Evaluation of C2 Taxol Analogs,” Bioorg. & Med. Chem. Lett., 1994, vol. 4, No. 3, pp. 479-482.
Rimoldi, et al., “Modified Taxols, 9. Synthesis and Biological Evaluation of 7-Substituted Photoaffinity Analogues of Taxol,” J. Nat. Prod., 1993, vol. 56, pp. 1313-1330.
Kingston, D. G. I., “The Chemistry of Taxol,” Pharmacol. Ther., 1991, vol. 52, pp. 1-34.
Kingston, D. G. I., “Taxol: The Chemistry and Structure-Activity Relationships of a Novel Anticancer Agent,” Trends Biotechnol., 1994, vol. 12, pp. 222-227.
Nicolaou, et al., “Chemistry and Biology of Taxol,” Angew. Chem. Int. Ed. Engl., 1994, vol. 33, pp. 15-44.
Kingston, et al., “The Chemistry of Taxol, A Clinically Useful Anticancer Agent,” J. Nat. Prod., 1990, vol. 53, No. 1, pp. 1-12.
Guenard, et al. “Taxol and Taxotere: Discovery, Chemistry, and Structure-Activity Relationships,” Acc. Chem. Res., 1993, vol. 26, pp. 160-167.
Commercon, et al., “Partial Synthesis of Major Human Metabolites of Docetaxel,” Tetrahedron, 1994, vol. 50, No. 34, pp. 10289-10298.
Stratford, I. J., “Mechanisms of Hypoxic Cell Radiosensitization and the Development of New Sensitizers,” Int. J. Radiat. Oncol. Biol. Phys., 1982, vol. 8, pp. 391-398.
Biaglow, et al. “The Effects of Nitrobenzene Derivatives on Oxygen Utilization and Radiation Response of an in Vitro Tumor Model,” Radiat. Res., 1976, vol. 65, pp. 529-539.
The Board of Education (for an on behalf of the Trustees of Florida State University), et al. v. American Bioscience, Inc. and Chunlin Tao, United States Court of Appeal for the Federal Circuit Court Decision, Case No. 02-1109, Decided Jun. 23, 2003, 22 pages.
Holton Robert A.
Nadizadeh Hossain
Yang Li-Xi
Dentz Bernard
Florida State University
Senniger Powers
LandOfFree
Radiosensitizing taxanes and their pharmaceutical preparations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiosensitizing taxanes and their pharmaceutical preparations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiosensitizing taxanes and their pharmaceutical preparations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3642556